Stool transition time, pathogen levels, microbiota status and more…the European Food Safety Authority has published some accepted measures of gut health but the industry wants more. For many in this sector, more validated biomarkers are the crucial next step for the sector to develop and affirm claims. But how achievable are they? How and when can trials be designed to utilize them?
Stool transition time, pathogen levels, microbiota status and more…the European Food Safety Authority has published some accepted measures of gut health but the industry wants more. For many in this sector, more validated biomarkers are the crucial next step for the sector to develop and affirm claims. But how achievable are they? How and when can trials be designed to utilize them?